NCT06579469

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-01-20Est. Completion: 2027-03

Enrollment target: 100 participants

Locations

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Primary Children's Hospital, Salt Lake City, Utah, United States
Seattle Childrens Hospital, Seattle, Washington, United States
Children's Hospital of Wisconsin., Milwaukee, Wisconsin, United States

Contact

Rebecca Epperly, MDreferralinfo@stjude.org 888-226-4343

Other microbiome trials you might be interested in

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy ParticipantsPhase 1Recruiting

Malaria, Falciparum

This is a single-centre, participant- and investigator-blind, randomised, placebo controlled, single ascending dose stud…

Nottingham, United KingdomEst. completion Dec 2, 2027

View Trial →

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerPhase 3Recruiting

Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2-Negative Breast CarcinomaHormone Receptor-Positive Breast Carcinoma

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chem…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.